Evidence map›Paper›PMID 38003022›Full record

ArticleGenes2023

SNP Array Screening and Long Range PCR-Based Targeted Next Generation Sequencing for Autosomal Recessive Disease with Consanguinity: Insight from a Case of Xeroderma Pigmentosum Group C.

Fumie Nomura, Akira Shimizu, Sumihito Togi, Hiroki Ura, Yo Niida

Abstract readCase Reports
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Two Novel Compound HeterozygousInternational journal of general medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fumie NomuraDepartment of Dermatology, Kanazawa Medical University, Uchinada 920-0293, Japan.
Akira ShimizuDepartment of Dermatology, Kanazawa Medical University, Uchinada 920-0293, Japan.
Sumihito TogiCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0002-3189-8111
Hiroki UraCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0002-7600-3481
Yo NiidaCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0001-5641-7962

Funding

Kanazawa Medical University No. 11181, 26699
6 · The paper itself

Abstract

Advances in genetic technologies have made genetic testing more accessible than ever before. However, depending on national, regional, legal, and health insurance circumstances, testing procedures may still need to be streamlined in real-world clinical practice. In cases of autosomal recessive disease with consanguinity, the mutation locus is necessarily isodisomy because both alleles originate from a common ancestral chromosome. Based on this premise, we implemented integrated genetic diagnostic methods using SNP array screening and long range PCR-based targeted NGS in a Japanese patient with xeroderma pigmentosum (XP) under the limitation of the national health insurance system. SNP array results showed isodisomy only in

Indexed as

Xeroderma PigmentosumConsanguinityHigh-Throughput Nucleotide SequencingHumansPolymerase Chain Reactionautosomal recessiveconsanguinityisodisomylong range PCR-based NGSSNP arrayxeroderma pigmentosum group C

Identifiers

PMID38003022
PMCPMC10671442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.